key: cord-0723773-c20nx2w4 authors: Skeens, Micah A.; Hill, Kylie; Olsavsky, Anna; Buff, Kimberly; Stevens, Jack; Akard, Terrah Foster; Shah, Nilay; Gerhardt, Cynthia A. title: Factors affecting COVID‐19 vaccine hesitancy in parents of children with cancer date: 2022-04-05 journal: Pediatr Blood Cancer DOI: 10.1002/pbc.29707 sha: f6f9cc0c1936934ce03c3ce0448e6244b0f5e763 doc_id: 723773 cord_uid: c20nx2w4 AIM: Little research exists on coronavirus (COVID‐19) vaccine hesitancy among caregivers of children with cancer. We aimed to (a) describe vaccine hesitancy in parents of children with cancer for both their child and self, and (b) examine the mediating role of parent‐reported COVID impact on the association between COVID exposure and vaccine hesitancy. PROCEDURE: We conducted a national survey of parents of children with cancer via Facebook and Momcology, a pediatric cancer community‐based organization recruited February–May 2021. Parents completed standardized measures online. A series of mediation models assessed the role of COVID‐19 impact (e.g., effects on parenting and well‐being) on associations between COVID‐19 exposure (e.g., direct/indirect exposure) and vaccine hesitancy. Moderation models examined the role of treatment status, COVID‐19 exposure, impact, and vaccine hesitancy. RESULTS: Parents (n = 491; 90% mothers; 93% White) reported moderate vaccine hesitancy (M = 2.08, SD = 0.76). Specifically, 18.5% (n = 90) reported they would not vaccinate their child, and 24.4% (n = 119) would only consider vaccination. Parents expressed higher concerns about vaccine side effects for their children (M = 3.01, SD = 0.95) than for themselves (M = 2.61, SD = 1.03; t[479] = 9.07, p < .01). Mediation analysis revealed a significant indirect effect of impact (95% CI [−0.013, −0.001]) on the association between higher exposure and higher vaccine hesitancy (b = .02, p = .06). There was no moderating effect of treatment status. Income remained a significant covariate (b = −.11, p < .01). CONCLUSION: Lower parent‐reported COVID exposure, higher COVID impact, concern for side effects, and lower income may be important factors related to vaccine hesitancy among parents of children with cancer. Providers of childhood cancer survivors should address vaccine hesitancy and potential health risks. The novel coronavirus (COVID- 19) global pandemic began in early 2020 and has caused almost one million deaths in the United States. 1 Children, in general, have had lower rates of medical complications due to the illness; however, pediatric cancer patients may be more vulnerable to COVID-19 infection, with high viral loads, weeks of virus shedding, 2 and increased risk for severe or fatal COVID-19 infection. 3, 4 Furthermore, children with cancer and their parents may experience even greater psychological distress and social isolation as a result of the pandemic. [5] [6] [7] COVID-19 vaccines have been recommended for individuals with cancer, including children over the age of 12, to prevent potential infection. [8] [9] [10] COVID-19 vaccines could dramatically reduce not only the physical effects of infection, but also the marked social impact of the pandemic for children. For example, school closures due to COVID-19 affected more than 57 million children and worsened achievement gaps and food insecurity. 11, 12 Pediatric COVID-19 vaccination could also restore extracurricular activities that have substantial benefits for children, such as increased physical activity and peer interaction. Thus, widespread vaccination could drastically reduce the need for public safety measures that have compounded the psychosocial impact of cancer treatment (e.g., isolation, school absences) on children. Despite the potential benefits, COVID-19 vaccine hesitancy continues to be a major threat to the successful implementation of vaccination. Vaccine hesitancy is defined as the delay in acceptance, reluctance, or refusal of vaccination 13, 14 and was designated by the World Health Organization as a top 10 leading threat to global health prior to the COVID-19 pandemic. 15 Specific to cancer and COVID-19, a recent survey reported 30% of adults with cancer were unsure or had no intent to receive the COVID-19 vaccine. 16 The most common reason for vaccine hesitancy was fear of side effects. For those willing to receive the vaccine, the strongest predictors included vaccination of family and friends and physician recommendation. Parents have expressed vaccine hesitancy related to influenza and other routine childhood vaccinations, 15 with one in eight expressing concern related to vaccine safety. Determining the degree of vaccine hesitancy and dis- 15 The VHS survey is psychometrically validated and comprised 10 items, including dimensions of vaccine confidence and vaccine risks. 21 The modified version includes eight items and rated on a four-point Likert scale rather than a five-point response scale due to removal of the "neutral" option given evidence that omitting the "neutral" option decreases the potential for socially desirable responding. 22 The wording was further modified to assess parent beliefs regarding COVID-19 vaccination for their child rather than general childhood or influenza vaccines. Parents' responses to each of the eight items were averaged to calculate a composite VHS score. The two questions asking about concern for side effects were reverse scored. Lower scores reflect greater vaccine hesitancy. The Cronbach's alpha for our sample was .93. Data were analyzed using SPSS software, version 26 for Windows. Descriptive statistics (M, SD, frequencies) were calculated for demographic characteristics and primary variables of interest. To identify potential covariates prior to running multivariate models, Pearson (α = .05; two-way) correlations were conducted between primary dependent variables (i.e., vaccine hesitancy) and demographic factors (e.g., parent age, parent sex, prior income, child age at diagnosis, treatment status). Pearson correlations were also used to examine associations between primary dependent variables (i.e., vaccine hesitancy) and COVID-19 exposure and COVID-19 impact scores. The PROCESS macro for SPSS was used to conduct moderated mediation analysis using ordinary least squares regression in four separate models. 23 The sample included 491 parents who completed self-report and proxy report on their child with cancer (Table 1) . On average, parents were 38.79 years old (SD = 6.85), and most participants were mothers (90%, TA B L E 2 Child demographic characteristics (N = 491) Child age in years (SD) 9. 16 Table 2 ). The average age at cancer diagnosis was 5.69 (SD = 4.02), and 45% of children were off-treatment (n = 221) at the time of study. On a scale of 0-25, the overall mean COVID-19 exposure score was The average vaccine hesitancy score among this sample was 2.92 (SD = 0.76) on a scale of 1-4 (1: not likely, 2: will consider, 3: very likely, 4: will vaccinate), reflecting low to moderate hesitancy. Figure 1 describes responses to individual items related to vaccine hesitancy. Table 3 includes correlations between demographic factors and variables of interest. Greater vaccine hesitancy was associated with younger parent age (r = −.24, p < .01), male parent sex (r = −.14, p < .01), and lower prior income (r = −.30, p < .01). Greater vaccine hesitancy was also significantly correlated with younger child age at diagnosis (r = −.09, p = .049) and being on treatment (r = .13, p < .01). Parents who reported greater vaccine hesitancy had higher COVID-19 exposure scores (r = .13, p < .01) and lower COVID-19 impact scores While correlations with parent age and income were moderate sized, the remaining associations were relatively weak. While controlling for parent age, parent sex, prior family income, In this nationwide study, US parents of children with cancer had moderate levels of COVID-19 vaccine hesitancy. Parents were more likely to report an intention to vaccinate themselves than their child, and they also reported less concern about side effects for themselves than for their child. Additional correlates of vaccine hesitancy included younger parent age, male parent sex, lower income, the child being off-treatment, lower parent-reported COVID-19 exposure, and higher COVID-19 impact. In multivariate models, greater COVID-19 impact mediated the association between higher COVID-19 exposure and less vaccine hesitancy regardless of the child's treatment status. However, the final model only explained a small portion (13%) of the variation in overall vaccine hesitancy. While few studies have reported COVID-19 vaccine hesitancy rates specifically in parents of children with cancer, hesitancy rates in this cohort were twice as high as the previously reported rate of 19% in adults with comorbid conditions, including cancer. 24 Rates from our study were also higher than the previously reported rate of 37.1% in adolescent and young adult cancer survivors. 25 COVID-19 vaccine hesitancy rates in the general population range from 25% to 53%. [26] [27] [28] This suggests parents of children with cancer may have comparable to slightly more vaccine hesitancy than other populations. COVID-19 vaccine hesitancy rates are almost double to that of influenza vaccine hesitancy rates previously reported in children. 15, 29 Interestingly, parents were more hesitant to vaccinate their child than themselves. This is likely due to the unknown side effects of the COVID-19 vaccine in children. Despite numerous studies that refute long-term, adverse effects of vaccinations, adverse effects and safety concerns remain the largest determinants of whether or not parents vaccinate their children. 15, 30 In this study, most parents expressed concern about the potential side effects of the vaccine for both their child and themselves. A recent study utilizing a provider-delivered webinar demonstrated increased COVID-19 vaccine enthusiasm in adults with cancer. 16 Our results may inform targeted interventions to increase COVID-19 vaccination rates in children with cancer. Although the clinical development of COVID-19 vaccines has progressed at rapid speed, an unadministered vaccine dose does not provide benefit. Public vaccination acceptance is closely associated with vaccination confidence and hesitancy. Decreasing hesitancy rates in parents of children with cancer, with special attention to those of lower income, off-treatment, and higher COVID-19 impact, is needed to ensure all children with cancer are protected. Oncology providers are encouraged to offer COVIDspecific education and messaging about the vaccine, which has been shown to be effective in other research. Helping families gain direct access to vaccines at the treating hospital or in their communities may also help. Micah A. Skeens conceptualized and designed the study, designed the data collection instruments, collected data, drafted the initial manuscript, and reviewed and revised the manuscript. Cynthia A. Gerhardt assisted with design of the study and data collection instruments, drafted initial manuscript, and reviewed and revised the manuscript. Kylie Hill and Anna Olsavsky carried out the initial analyses and reviewed and revised the manuscript. Terrah Foster Akard assisted with methodology, reviewed and revised the manuscript, and critically reviewed the manuscript for important intellectual content. Kimberly Buff assisted with methodology, and reviewed and revised the manuscript. Jack Stevens, Nilay Shah, and Terrah Foster Akard reviewed and revised the manuscript and critically reviewed the manuscript for important intellectual content. All authors approved the final version of the manuscript as submitted and agree to be accountable for all aspects of the work. The data that support the findings of this study are available from the corresponding author upon reasonable request. An interactive web-based dashboard to track COVID-19 in real time Pediatric cancer research: surviving COVID-19 COVID-19 in immunocompromised patients: a systematic review of cancer, hematopoietic cell and solid organ transplant patients Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak Psychological distress during the 2019 coronavirus disease (COVID-19) pandemic among cancer survivors and healthy controls Psychological symptoms of cancer survivors during the COVID-19 outbreak: a longitudinal study Impacts of COVID-19 on caregivers of childhood cancer survivors COVID-19 vaccines for patients with cancer: benefits likely outweigh risks The Advisory Committee on Immunization Practices' updated interim recommendation for allocation of COVID-19 vaccine-United States COVID-19 vaccine & patients with cancer COVID-19, school closures, and child poverty: a social crisis in the making Projecting the potential impact of COVID-19 school closures on academic achievement Vaccine hesitancy and refusal Vaccine hesitancy: definition, scope and determinants Parental hesitancy about routine childhood and influenza vaccinations: a national survey Vaccine enthusiasm and hesitancy in cancer patients and the impact of a webinar Influence of pediatric cancer-related financial burden on parent distress and other stress-related symptoms An assessment of equivalence between online and mail surveys in service research A tale of two sample sources: do results from online panel data and conventional data converge? COVID-19 exposure and family impact scales: factor structure and initial psychometrics Assessing vaccine hesitancy in the UK population using a generalized vaccine hesitancy survey instrument Evidence-based survey design: the use of a midpoint on the Likert scale Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach COVID-19 vaccine hesitancy among individuals with cancer, autoimmune diseases, and other serious comorbid conditions: cross-sectional, internet-based survey COVID-19 vaccine hesitancy among adolescent and young adult cancer survivors Predictors of willingness to get a COVID-19 vaccine in the U.S Factors associated with COVID-19 vaccine hesitancy COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates Parental vaccine hesitancy and childhood influenza vaccination Addressing parental vaccine hesitancy and other barriers to childhood/adolescent vaccination uptake during the coronavirus (COVID-19) pandemic. Front Immunol Integrating primary care providers in the care of cancer survivors: gaps in evidence and future opportunities Unique needs of childhood cancer survivors during the COVID-19 pandemic The PANDEMIC framework for encouraging COVID-19 vaccinations Four messages that can increase uptake of the COVID-19 vaccines Effects of different types of written vaccination information on COVID-19 vaccine hesitancy in the UK (OCEANS-III): a single-blind, parallel-group, randomised controlled trial Factors affecting COVID-19 vaccine hesitancy in parents of children with cancer The authors report no conflicts of interest or relevant financial relationships.